Compound and method for treating cancer |
Title: |
Compound and method for treating cancer |
|
Application Number: |
200410068867 |
Application Date: |
2004/07/13 |
Announcement Date: |
2006/01/18 |
Pub. Date: |
|
Publication Number: |
1721428 |
Announcement Number: |
|
Grant Date: |
|
Granted Pub. Date: |
|
ApplicationType: |
Invention |
State/Country: |
11[China|beijing] |
IPC: |
C07H 21/00, C12N 9/22, C12N 15/55, A61K 31/395, A61P 35/00, C12Q 1/68, G01N 33/574, G01N 33/68 |
Applicant(s): |
Tumor institute, Tumor Hospital, Chinese Academy of Medical Sciences |
Inventor(s): |
Liu Zhihua, Zhang Liyong, Ding Fang, Li Yanda, Feng Wangqin, Feng Fengzhi, Cui Zhumei |
Key Words: |
Compound, method, treating cancer |
Abstract: |
The present invention provides is the compound and method of lowering SLP-2 expression or inhibiting SLP-2 protein activity to treat cancer. Specifically, the present invention discloses antisense oligonucleotide, nucleic acid, antibody, oligonucleotide adaptor, their arbitrary combination, or medicine containing them capable of lowering SLP-2 expression. The present invention also discloses method of detecting cancer and screening anticancer medicine. The said cancer is preferably high SLP-2 expression cancers, especially esophagus squamous carcinoma, endometium cancer and/or lung cancer. |
Claim: |
|
Priority: |
|
PCT: |
|
LegalStatus: |
|
Relevancy information |
|
|
|
|
Last Update |
|
|
 |
2008-4-17 |
|
Selected patents owned by Tsinghua University filed in 2005 are loaded. |
 |
2008-3-31 |
|
Selected patents owned by Tsinghua University filed in 2006 and 2007 are load. |
|
|